These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21428976)

  • 1. Serum CCL13 levels in patients with systemic sclerosis and controls.
    Gambichler T; Yilmaz E; Höxtermann S; Kolios A; Moritz R; Bechara FG; Kreuter A
    Br J Dermatol; 2011 Jul; 165(1):216-8. PubMed ID: 21428976
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
    Yanaba K; Komura K; Kodera M; Matsushita T; Hasegawa M; Takehara K; Sato S
    Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL13 is a promising diagnostic marker for systemic sclerosis.
    Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S
    Br J Dermatol; 2010 Feb; 162(2):332-6. PubMed ID: 19747218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage oligomeric matrix protein in systemic sclerosis.
    Yamamoto M; Takahashi H; Suzuki C; Naishiro Y; Yamamoto H; Imai K; Shinomura Y
    Rheumatology (Oxford); 2007 Dec; 46(12):1858-9. PubMed ID: 17895282
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of cardiac laboratory markers in patients with systemic sclerosis.
    Montagnana M; Lippi G; Volpe A; Salvagno GL; Biasi D; Caramaschi P; Cesare Guidi G
    Clin Biochem; 2006 Sep; 39(9):913-7. PubMed ID: 16713594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High circulating levels of VEGF-C suggest abnormal lymphangiogenesis in systemic sclerosis.
    Chitale S; Al-Mowallad AF; Wang Q; Kumar S; Herrick A
    Rheumatology (Oxford); 2008 Nov; 47(11):1727-8. PubMed ID: 18820309
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum matrix metalloproteinase-3 in systemic sclerosis.
    Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
    Arch Dermatol Res; 2004 Jun; 296(1):25-9. PubMed ID: 15095096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
    Carulli MT; Handler C; Coghlan JG; Black CM; Denton CP
    Ann Rheum Dis; 2008 Jan; 67(1):105-9. PubMed ID: 17604287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Type IV collagen and laminin levels in the sera from patients with systemic scleroderma (PSS)].
    Kanaizuka I; Sasaki T; Nakajima H
    Nihon Hifuka Gakkai Zasshi; 1991 Jul; 101(8):819-23. PubMed ID: 1942585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.
    Hara T; Ogawa F; Yanaba K; Iwata Y; Muroi E; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2009 Jan; 36(1):99-105. PubMed ID: 19208531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
    Jinnin M; Makino T; Kajihara I; Honda N; Makino K; Ogata A; Ihn H
    Br J Dermatol; 2010 Apr; 162(4):751-8. PubMed ID: 19886888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of soluble interleukin-2 receptor--a possible index of disease prognosis in systemic sclerosis.
    Lis A; Brzezińska-Wcisło L; Rubisz-Brzezińska J; Kulawik I
    Clin Exp Dermatol; 1997 Jan; 22(1):60-1. PubMed ID: 9330064
    [No Abstract]   [Full Text] [Related]  

  • 13. [Soluble receptors of cytokines in sera of patients with systemic sclerosis--clinical correlation].
    Lis AD; Brzezińska-Wcisło LA
    Wiad Lek; 2003; 56(11-12):532-6. PubMed ID: 15058159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis.
    Hasegawa M; Fujimoto M; Hamaguchi Y; Matsushita T; Inoue K; Sato S; Takehara K
    J Rheumatol; 2011 May; 38(5):877-84. PubMed ID: 21239758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease.
    Wuttge DM; Wildt M; Geborek P; Wollheim FA; Scheja A; Akesson A
    Arthritis Res Ther; 2007; 9(5):R85. PubMed ID: 17784951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
    Young-Min SA; Beeton C; Laughton R; Plumpton T; Bartram S; Murphy G; Black C; Cawston TE
    Ann Rheum Dis; 2001 Sep; 60(9):846-51. PubMed ID: 11502611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of serum hyaluronan levels in systemic sclerosis: association with disease severity.
    Yoshizaki A; Iwata Y; Komura K; Hara T; Ogawa F; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2008 Sep; 35(9):1825-9. PubMed ID: 18688912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum interleukin 23 in patients with systemic sclerosis.
    Komura K; Fujimoto M; Hasegawa M; Ogawa F; Hara T; Muroi E; Takehara K; Sato S
    J Rheumatol; 2008 Jan; 35(1):120-5. PubMed ID: 18085738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating thrombopoietin in systemic sclerosis.
    Ertenli I; Kiraz S; Ertürk H; Haznedaroglu IC; Celik I; Calgüneri M; Kirazli S
    J Rheumatol; 1999 Sep; 26(9):1939-41. PubMed ID: 10493673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.